Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1983]
News [3212]
Articles [134]
Editorials [3]
Conferences [121]
elearning [18]
Chemokine CCL2 recruits inflammatory monocytes to facilitate breast tumour metastasis
Chemokine CCL2 recruits inflammatory monocytes to facilitate breast tumour metastasis
OECI quality certificate for five cancer centres in Europe
OECI quality certificate for five cancer centres in Europe
Intermittent versus continuous chemotherapy in advanced colorectal cancer: Results from the COIN trial
Intermittent versus continuous chemotherapy in advanced colorectal cancer: Results from the COIN trial
ASCO 2011: World's leading cancer organisations announce new efforts in response to global cancer crisis
ASCO 2011: World's leading cancer organisations announce new efforts in response to global cancer crisis
Addition of cetuximab to oxaliplatin-based chemotherapy in advanced colorectal cancer: Results from the COIN trial
Addition of cetuximab to oxaliplatin-based chemotherapy in advanced colorectal cancer: Results from the COIN trial
ASCO 2011: Three years of imatinib improves survival for high-risk gastrointestinal stromal tumours
ASCO 2011: Three years of imatinib improves survival for high-risk gastrointestinal stromal tumours
ASCO 2011: Extending pemetrexed treatment as maintenance therapy improves progression-free survival for advanced lung cancer
ASCO 2011: Extending pemetrexed treatment as maintenance therapy improves progression-free survival for advanced...
ASCO 2011: Suggested benefit of bevacizumab for newly diagnosed ovarian cancer patients at high risk of recurrence
ASCO 2011: Suggested benefit of bevacizumab for newly diagnosed ovarian cancer patients at high risk of recurrence
ASCO 2011: Circulating tumour cells as surrogate for survival in prostate cancer
ASCO 2011: Circulating tumour cells as surrogate for survival in prostate cancer
ASCO 2011: 'Driver' mutations identified for advanced lung cancer
ASCO 2011: 'Driver' mutations identified for advanced lung cancer

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation